CV ASC Registry Education-Seq#5033 (New Antiarrhythmic Therapy Initiated Prior to Cath Lab)

Seq#5033 (New Antiarrhythmic Therapy Initiated Prior to Cath Lab)

Video Transcription

Video Summary

Antiarrhythmic therapy initiated prior to catheterization lab aims to determine if a patient recently started new medication for abnormal heart rhythms. Drugs like atropine and adenosine, administered for acute rhythm treatment, are not considered long-term solutions and are not included in this assessment. The focus is on identifying patients who received a new antiarrhythmic drug within the last 30 days to manage abnormal heart rhythms before the procedure.

Keywords

antiarrhythmic therapy

catheterization lab

medication

abnormal heart rhythms

30 days